C3 and lupus nephritis: Moreover, N termini profiling of plasma from six patients with lupus nephritis (a severe manifestation of SLE and important predictor of morbidity (Weinstein et al, 2021)), before and after remission-inducing therapy, revealed a marked decline in C3-LHF1 upon remission.